The company
NexGel, Inc
NXGL · Nasdaq
NXGL stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 43.4% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 29% -5 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $68K
- Officials’ trades on record
- 0
- Institutions holding
- 16 (+2)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Adam R. LevyChief Executive Officer | sold | 5,000at $0.5933 | 23 Jun 2026filed 23 Jun 2026 |
| Adam R. LevyChief Executive Officer | sold | 6,000at $0.5921 | 18 Jun 2026filed 23 Jun 2026 |
| Adam R. LevyChief Executive Officer | sold | 3,000at $0.6136 | 11 Jun 2026filed 15 Jun 2026 |
| Adam R. LevyChief Executive Officer | sold | 3,000at $0.547 | 8 Jun 2026filed 9 Jun 2026 |
| Adam R. LevyChief Executive Officer | sold | 3,000at $0.5936 | 4 Jun 2026filed 9 Jun 2026 |
| Adam R. LevyChief Executive Officer | sold | 2,000at $0.5859 | 1 Jun 2026filed 3 Jun 2026 |
| Adam R. LevyChief Executive Officer | sold | 3,000at $0.6003 | 29 May 2026filed 29 May 2026 |
| Adam R. LevyChief Executive Officer | sold | 7,000at $0.6058 | 28 May 2026filed 29 May 2026 |
| Adam R. LevyChief Executive Officer | sold | 3,000at $0.5975 | 27 May 2026filed 29 May 2026 |
| Adam R. LevyChief Executive Officer | bought | 100,000at $0.60 | 14 May 2026filed 18 May 2026 |
| Adam R. LevyChief Executive Officer | bought | 50,000at $0.00 | 14 May 2026filed 18 May 2026 |
| Scott Robert HenryDirector | bought | 41,667at $0.60 | 14 May 2026filed 18 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 2026 | 85,140$43K | +85,140 |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 71,863$36K | -56,673−44.1% |
| MORGAN STANLEYunchanged · filed 13 Aug 2026 | 54,980$28K | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 2026 | 48,920$25K | +48,920 |
| CITADEL ADVISORS LLCnew · filed 14 Aug 2026 | 40,976$21K | +40,976 |
| VANGUARD FIDUCIARY TRUST COnew · filed 13 Aug 2026 | 34,040$17K | +34,040 |
| UBS Group AGadded · filed 13 Aug 2026 | 24,735$12K | +18,101+272.9% |
| JANE STREET GROUP, LLCreduced · filed 14 Aug 2026 | 20,606$10K | -21,532−51.1% |
| STATE STREET CORPunchanged · filed 7 Aug 2026 | 17,259$8,647 | 00.0% |
| NORTHERN TRUST CORPnew · filed 13 Aug 2026 | 13,431$6,729 | +13,431 |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.